Banque Cantonale Vaudoise Lowers Stock Holdings in HCA Healthcare, Inc. $HCA
MarketBeat
Last updated: May 21, 2026
HCA Healthcare, Inc. (NYSE:HCA) is a publicly traded healthcare company whose stock performance and institutional investor activity are being closely monitored. Recent reports indicate mixed analyst sentiment and adjustments to price targets, alongside the company's operational initiatives and financial performance.
- Institutional investors have shown varied activity in HCA Healthcare. Banque Cantonale Vaudoise significantly reduced its stake by 36.8% in the fourth quarter, selling 3,176 shares. In contrast, several other funds increased their holdings. Capital World Investors boosted its stake by 3.8%, Arrowstreet Capital Limited Partnership by 1.8%, Viking Global Investors LP by 58.5%, Legal & General Group Plc by 0.8%, and Invesco Ltd. by 1.1%. Overall, institutional investors hold 62.73% of the company's stock.
- HCA Healthcare recently reported first-quarter earnings, with EPS of $7.15, missing analyst estimates by $0.04, though revenue of $19.11 billion slightly exceeded consensus. The company has provided FY 2026 guidance of $29.100-$31.500 EPS, with analysts projecting $30.07 EPS for the current fiscal year. A quarterly dividend of $0.78 per share will be paid on June 30th, resulting in an annualized dividend of $3.12 and a dividend yield of 0.8%.
- Analyst ratings are predominantly positive, with a consensus "Moderate Buy" rating, though specific price target adjustments have been made. JPMorgan, for example, lowered its price target from $535 to $490 while maintaining a neutral rating. Other reports highlight the company's community service initiatives, with colleagues volunteering over 41,800 hours.
